NCT06195644

Brief Summary

This study will be conducted to investigate the following:

  1. 1.The impact of implementing GVS in MS rehabilitation on cortical excitability.
  2. 2.The influence of GVS on upper limb function in patients diagnosed with MS. Patients will be randomly assigned to a control group (Conventional Physical Therapy program = CPT) and a study group (Galvanic Vestibular Stimulation = GVS in addition to the conventional program) subsequently. CPT will perform moderate intensity aerobic training (arm ergometer) and task oriented hand manipulation training, while GVS will receive Galvanic Vestibular Stimulation will be added to the conventional physical Therapy program.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Sep 2023

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 3, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 8, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 8, 2024

Status Verified

December 1, 2023

Enrollment Period

1.2 years

First QC Date

December 11, 2023

Last Update Submit

December 22, 2023

Conditions

Keywords

Galvanic Vestibular StimulationHand DexterityMultiple SclerosisTranscranial magnetic StimulationCortical excitability

Outcome Measures

Primary Outcomes (2)

  • Cortical changes

    central motor conduction time is the time taken for neural impulses to travel through the central nervous system on their way to the target muscles.

    15 minutes

  • Upper Limb motor dexterity

    Nine hole peg test 9 HPT

    15-20 minutes

Secondary Outcomes (3)

  • Advanced dexterity (Handwriting analysis) by MovAlyzeR® software

    15-20 minutes

  • Balance

    15-20 minutes

  • Fatigue

    15-20 minutes

Study Arms (2)

GVS group

EXPERIMENTAL

Galvanic Vestibular Stimulation in addition to the Conventional Physical Therapy program of moderate intensity aerobic training on cyclic ergometer for upper limb and task oriented training for hand dexterity.

Device: Galvanic vestibular stimulationDevice: MovAlyzeR® software from NeuroscriptDevice: BODYFIT Mini Portable Pedal Home Exerciser (cyclic ergometer)

CPT group

ACTIVE COMPARATOR

Conventional Physical Therapy program of moderate intensity aerobic training on cyclic ergometer for upper limb and task oriented training for hand dexterity.

Device: MovAlyzeR® software from NeuroscriptDevice: BODYFIT Mini Portable Pedal Home Exerciser (cyclic ergometer)

Interventions

galvanic current generated by Gymna DUO 200 and delivered through conductive medium (electrode gel) by two small carbon rubber electrodes 3 cm 2 each bilaterally over two mastoid processes for 30 minutes, two times per week for 12 weeks .

GVS group

MovAlyzeR® movement analysis software from Neuroscript turns a pen tablet or mouse into a high-quality system for examining movements by a pen, mouse or finger. Hence, it can train and analyze hand dexterity and handwriting using pen tablets such as sentence parameters.

CPT groupGVS group

stationary upper body pedaling as a moderate intensity aerobic training

CPT groupGVS group

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with ataxic RRMS type of both genders will be recruited. The last MS relapse occurred at least 3 months prior to the study.
  • Patients' age will range from 20 to 45 years old.
  • Ambulant Patients who meet the level less than or equal to 5 on EDSS will be recruited.
  • Patients' score on Mini Mental State Examination should be \> 26.
  • Mild or no spasticity (grade 1 or 1+) according to Modified Ashworth Scale.
  • All patients must at least hold Primary stage certificate of education from one of the Egyptian educational authorities.
  • All patients can independently sign consent form

You may not qualify if:

  • Patients will be excluded if they have:
  • Moderate to severe auditory or visual or cognitive impairment.
  • Coexistence of other neurological diagnoses of Central or Peripheral Nervous system (e.g. cerebrovascular stroke, vestibulopathy or polyneuropathy).
  • History of any problems that hinder conduction of aerobic training or magnetic stimulation (e.g. deep venous thrombosis, shunts and pacemakers).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

December 11, 2023

First Posted

January 8, 2024

Study Start

September 3, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

January 8, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations